Table 4.
Univariate and multivariate Cox proportional regression analysis of factors associated with OS and DFS in patients selected in the PSM model (N = 82)
| Variables | Overall survival | Disease-free survival | ||||||
|---|---|---|---|---|---|---|---|---|
| Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
| HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | |
| Age, > 50 years vs ≤ 50 years | 1.422 (0.792–2.552) | 0.238 | 1.122 (0.647–1.945) | 0.682 | ||||
| Gender, male vs female | 1.647 (0.793–3.420) | 0.181 | 1.372 (0.668–2.819) | 0.389 | ||||
| HBsAg, positive vs negative | 0.578 (0.303–1.102) | 0.096 | 0.767 (0.409–1.441) | 0.411 | ||||
| Liver cirrhosis, yes vs no | 1.201 (0.608–2.371) | 0.597 | 0.937 (0.506–1.734) | 0.836 | ||||
| Child–Pugh score, B vs A | 0.684 (0.245–1.911) | 0.469 | 0.542 (0.195–1.505) | 0.240 | ||||
| Edmonson stage, III-IV vs I-II | 1.664 (0.910–3.041) | 0.098 | 1.347 (0.771–2.353) | 0.296 | ||||
| No. of tumors, multiple vs single | 1.530 (0.841–2.784) | 0.164 | 1.687 (0.960–2.964) | 0.069 | ||||
| Largest tumor size, > 5 vs ≤ 5 cm | 1.640 (0.508–5.294) | 0.408 | 2.066 (0.643–6.641) | 0.223 | ||||
| AFP, ≥ 400 vs < 400 ng/mL | 1.302 (0.712–2.380) | 0.392 | 1.680 (0.945–2.988) | 0.077 | ||||
| BCLC stage, B-C vs 0-A | 21.320 (0.020–22,572.489) | 0.389 | 21.436 (0.037–12,308.272) | 0.344 | ||||
| PVTT, yes vs no | 7.448 (3.581–15.490) | 0.000 | 5.619 (2.413–13.087) | 0.000 | 4.879 (2.610–9.119) | 0.000 | 3.890 (1.814–8.342) | 0.000 |
| Preoperative CTCs, ≥ 2 vs < 2 | 5.940 (3.152–11.197) | 0.000 | 3.737 (1.660–8.412) | 0.001 | 4.974 (2.757–8.973) | 0.000 | 2.465 (1.139–5.334) | 0.022 |